Nurix Therapeutics (NRIX) Amortizatization of Intangibles (2020 - 2026)

Nurix Therapeutics (NRIX) has reported Amortizatization of Intangibles for 7 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Amortizatization of Intangibles fell 42.35% year-over-year to $1.6 million; the TTM figure through May 2026 stood at $7.6 million (down 43.53% YoY), while the FY2025 annual figure was $10.3 million, down 8.56% from the prior year.
• Amortizatization of Intangibles eased to $1.6 million in Q2 2026 per NRIX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $3.7 million in Q3 2024 and bottomed at -$542000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $1.7 million across 5 years, with a median of $1.9 million in 2024.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles plunged 144.14% — and 2023, when it surged 2081.93%.
• Nurix Therapeutics' Amortizatization of Intangibles stood at $650000.0 in 2022, then jumped by 202.77% to $2.0 million in 2023, then jumped by 77.49% to $3.5 million in 2024, then tumbled by 46.55% to $1.9 million in 2025, then decreased by 16.6% to $1.6 million in 2026.
• Business Quant data shows NRIX's Amortizatization of Intangibles at $1.6 million in Q2 2026, $2.0 million in Q1 2026, and $1.9 million in Q4 2025.